In clinical trials, plasma levels of C1q, MBL, Bb, C4d, C3a, C5a, and C5b-9 in DKD patients are significantly higher than in diabetes patients without renal involvement (54), and urinary excretion of C3b, Bb, and MAC are also noted (34). This evidence concerns the gene C5 and diabetic kidney disease.